Sirolimus ocular formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sirolimus ocular formulation, covering 2013-01-10 to 2013-01-10. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration [Phase 1, Phase 2]